Rock Springs Capital Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Rock Springs Capital Management’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-100,000	Closed	-$1.92M	–	137
2018 Q4	$1.92M	Sell	100,000 -133,073	-57%	-$4.98M	0.09%	123
2018 Q3	$12.2M	Sell	233,073 -66,927	-22%	-$3.65M	0.44%	73
2018 Q2	$13M	Buy	300,000 +13,000	+5%	+$557K	0.5%	68
2018 Q1	$10.6M	Buy	287,000 +72,500	+34%	+$1.93M	0.45%	75
2017 Q4	$4.26M	Sell	214,500 -25,500	-11%	-$548K	0.19%	112
2017 Q3	$5.97M	Sell	240,000 -72,188	-23%	-$1.33M	0.28%	97
2017 Q2	$5.45M	Buy	+312,188	New	+$5.46M	0.28%	94

Other funds holding GTHX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Rock Springs Capital Management's GTHX Position: Q1 2019 in Review

Rock Springs Capital Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2019, closing a stake of 100,000 shares — an estimated $1.92M sold.

Rock Springs Capital Management first reported a position in GTHX in Q2 2017 and held it in 7 quarters. The position peaked at $13M in Q2 2018. 93 funds tracked by Wall St. Rank hold GTHX as of Q1 2019.

Rock Springs Capital Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Rock Springs Capital Management sold 100,000 G1 Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $1.92M.
Rock Springs Capital Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2017 and held it in 7 quarters.
Rock Springs Capital Management's G1 Therapeutics, Inc. Common Stock position peaked at $13M in Q2 2018.
93 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Rock Springs Capital Management's 13F filing for Q1 2019, filed 15 May 2019.